Cargando…

Immune checkpoint inhibitors in the treatment of virus-associated cancers

Among all malignant tumors that threaten human health, virus-related tumors account for a large proportion. The treatment of these tumors is still an urgent problem to be resolved. The immune system is the “guard” of the human body, resisting the invasion of foreign substances such as viruses. Studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Peipei, Lazare, Cordelle, Cao, Canhui, Meng, Yifan, Wu, Ping, Zhi, Wenhua, Lin, Shitong, Wei, Juncheng, Huang, Xiaoyuan, Xi, Ling, Chen, Gang, Hu, Junbo, Ma, Ding, Wu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558794/ https://www.ncbi.nlm.nih.gov/pubmed/31182108 http://dx.doi.org/10.1186/s13045-019-0743-4

Ejemplares similares

LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype
por: Cao, Canhui, et al.
Publicado: (2020)

Mapping long‐range contacts between risk loci and target genes in human diseases with Capture Hi‐C
por: Cao, Canhui, et al.
Publicado: (2020)

HPV‐CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing
por: Zhi, Wenhua, et al.
Publicado: (2022)

Clinical Value of Combining (18)F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma
por: Sookha, Rajiv Rai, et al.
Publicado: (2018)

Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing
por: Fan, Yubo, et al.
Publicado: (2018)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis
por: Lin, Shitong, et al.
Publicado: (2022)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Evaluation of Cervical Intraepithelial Neoplasia Occurrence Following the Recorded Onset of Persistent High-Risk Human Papillomavirus Infection: A Retrospective Study on Infection Duration
por: Lazare, Cordelle, et al.
Publicado: (2019)

Key Role of MCUR1 in Malignant Progression of Breast Cancer
por: Gao, Peipei, et al.
Publicado: (2021)

RAB2A promotes cervical cancer progression as revealed by comprehensive analysis of HPV integration and proteome in longitudinal cervical samples
por: Meng, Yifan, et al.
Publicado: (2022)

APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma
por: Peng, Ting, et al.
Publicado: (2022)

The exon 12‐containing LHX6 isoforms promote cervical cancer cell proliferation by regulating the MAPK signaling pathway
por: Wang, Ling, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
por: Chen, Xi, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020)

PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
por: Gao, Yuan, et al.
Publicado: (2022)

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
por: Zhang, Wenjing, et al.
Publicado: (2022)

Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population
por: Yu, Xiaoyuan, et al.
Publicado: (2022)

Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2023)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

Landscape of immune checkpoint inhibitor-related adverse events in Chinese population
por: Li, Li, et al.
Publicado: (2020)

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors
por: Wu, Zhaozhen, et al.
Publicado: (2021)

The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
por: Li, Ping, et al.
Publicado: (2018)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023)

Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
por: Pei, Wen-Guang, et al.
Publicado: (2023)

Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma
por: Peng, Lijun, et al.
Publicado: (2022)

Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
por: Martin, Spencer D., et al.
Publicado: (2023)

Drug therapy for myocarditis induced by immune checkpoint inhibitors
por: Wu, Yihao, et al.
Publicado: (2023)

Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review
por: Xu, Ling-Yi, et al.
Publicado: (2023)

Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)

Immune Checkpoint Inhibitors and the Heart
por: Mocan-Hognogi, Diana Larisa, et al.
Publicado: (2021)

Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and Neurotoxicity
por: Zhao, Zhiyi, et al.
Publicado: (2021)

Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
por: Li, Meng, et al.
Publicado: (2022)

Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
por: Gao, Ling, et al.
Publicado: (2019)

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
por: Liu, Hao, et al.
Publicado: (2023)

Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
por: She, Jianqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_koeiavihqp44ve61vuos1480r7